What this record means
The record shows a live, pending application for the mark WILTHERVA owned by SLSG Limited LLC, a Delaware limited‑liability company, and it is currently on the Principal Register. The only listed goods are in International Class 005 and consist of vaccines, cancer vaccines, pharmaceutical preparations for treating and preventing cancer, immunotherapeutic agents that are part of such preparations, and therapeutic agents that boost immune response against cancer; a later‑filed use‑in‑commerce statement will be required within six months of the Notice of Allowance dated July 7 2026. Because the coverage is limited to these pharmaceutical and immunotherapy products, a similar name used for unrelated goods—say, clothing or software—would be farther from the scope shown here, though the record does not give the owner control over every possible use of the word. The prosecution history shows the application was approved for publication on the Principal Register, then published for opposition on May 12 2026, and a Notice of Allowance was issued on July 7 2026; no enforcement actions such as oppositions or cancellations appear in the supplied history. I'd treat this as a meaningful concern if you plan a name in the same cancer‑treatment space, but the risk is lower for dissimilar product categories.
Informational only - not legal advice.